Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#2 clBTC clBTC +12.08%
#3 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.67%
#4 Mantle Staked Ether Mantle Staked Ether +8.27%
#5 Tutorial Tutorial +6.71%
#6 Palladium Network Palladium Network +6.69%
#7 OpenEden OpenEden +6.37%
#8 EfficientFrontier EfficientFrontier +5.09%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +4.66%
#10 Momentum Momentum +4.55%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
ProtoKinetix, Incorporated ProtoKinetix, Incorporated

ProtoKinetix, Incorporated

PKTX
Pozycja w akcjach #40253
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and... ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.
Cena akcji
$0.0005
Ostatnia synchronizacja: 2026-08-12
Kapitalizacja rynkowa
$195.79K
Zmiana (1 dzień)
25.00%
Zmiana (1 rok)
-92.06%
Kraj
US
Handel ProtoKinetix, Incorporated (PKTX)

Kategoria

Healthcare
Zyski dla ProtoKinetix, Incorporated (PKTX)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych ProtoKinetix, Incorporated, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy ProtoKinetix, Incorporated od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE